EyePoint EYPT
NASDAQ EYPT
$0.36 +0.00 (+0.53%)
At close: Nov 9, 2026 · 4:00 PM EST

EyePoint (EYPT) Sales of Property, Plant and Equipment (2014 - 2016)

Updated

EyePoint (EYPT) reported Sales of Property, Plant and Equipment of $155,000 for FY2025.

Analysis

EyePoint (EYPT) Sales of Property, Plant and Equipment (2014 - 2016) Analysis & Trends

  • The FY2025 figure ranks as the lowest annual Sales of Property, Plant and Equipment since FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -4.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 EyePoint 31.41 Mn -881.72 Mn 507,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 33,000.00
Jun 30, 2014 2,000.00
Mar 31, 2014 4,000.00
API Access

EyePoint Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=EYPT&period=max&api_key=YOUR_API_KEY